Global Patient Blood Management Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Instruments(Blood Processing Devices[Centrifuges, and Blood Cell Processors], Blood Transfusion Devices[ Apheresis Machines, Plasma & Plasma Component Separators, Cell Salvage Systems, and Others], Blood Culture Screening Devices[Automated Blood Culture Systems, and Supporting Laboratory Equipment], Diagnostic & Testing Instruments[PCR Instruments, Hematology Analyzers, NGS Platforms, and Blood Grouping Analyzers], Blood Storage Devices[Medical Refrigerators, and Medical Freezers], Syringes & Needles, Vials & Tubes, Blood Bags, and Others), Reagents & Kits(Culture Media, Reagents, Kits, and Others), Software.By Component;
Whole Blood, and Plasma.By End User;
Blood Banks, Hospitals, Diagnostic Clinics, and Pathology Labs.By Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Patient Blood Management Market (USD Million), 2021 - 2031
In the year 2024, the Global Patient Blood Management Market was valued at USD 15,116.13 million. The size of this market is expected to increase to USD 23,376.25 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.4%.
PBM focuses on optimizing the care of patients who might need transfusions, ensuring that blood transfusions are used appropriately, and employing strategies to minimize blood loss and maximize patient blood cell production. This approach not only enhances patient safety but also contributes to better clinical outcomes by reducing the risks associated with unnecessary transfusions, such as infections and immunological reactions. The rising prevalence of chronic diseases, increasing surgical procedures, and the growing awareness among healthcare providers about the benefits of PBM are further fueling market expansion.
Key components of the PBM market include blood conservation techniques, patient-specific blood management strategies, and advanced diagnostic technologies to monitor and manage patients’ hemoglobin levels effectively. These innovations are transforming the landscape of transfusion medicine, offering healthcare facilities opportunities to implement tailored approaches that align with individual patient needs and clinical protocols. Regulatory initiatives promoting evidence-based practices in blood management are shaping market dynamics globally, encouraging healthcare providers to adopt standardized protocols and guidelines. As the demand for efficient healthcare delivery continues to rise, coupled with the imperative to reduce healthcare costs, the Patient Blood Management market is poised for continued growth and innovation in the coming years.
Global Patient Blood Management Market Recent Developments
-
In 2019, Abbott (US) gained US FDA approval for its 'Alinity s' blood culture screening system and the Afinion HbA1c Dx assay kit.
-
in 2019, F. Hoffmann-La Roche LTD (Switzerland) received US FDA approval for its cobas Babesia Test, designed for donor screening.
-
In 2018, Terumo BCT (Japan) and Stafa Cellular Therapy (US) initiated a collaborative agreement to expand access to the StafaCT software within healthcare organizations.
-
In 2018, B. Braun Melsungen AG (Ireland) acquired the bloodlines business of NxStage Medical, Inc. (US), operating under the Medisystems brand.
-
In 2018, Abbott (US) received CE mark approval for its Alinity h-series, enabling its use within the European Union.
Segment Analysis
By Product, the market includes equipment, reagents, and software solutions used for blood collection, testing, storage, and monitoring. Each product type plays a critical role in ensuring safe and effective blood management, catering to needs in clinical settings and various healthcare facilities.
Component segmentation focuses on the different types of blood components managed and utilized, such as red blood cells, plasma, platelets, and whole blood. This analysis highlights the specific requirements for processing and handling each component, emphasizing the importance of proper storage and transfusion practices to maintain quality and safety.
End User segmentation breaks down the market by institutions such as hospitals, blood banks, diagnostic centers, and clinics. Hospitals are a primary end user, relying on patient blood management solutions for emergency procedures, surgeries, and routine transfusions. Blood banks depend on these products for blood collection, testing, and safe storage. Diagnostic centers and clinics use these tools for accurate blood analysis to guide patient treatment and care.
The Geography segment provides insights into regional trends and market performance across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Each region's healthcare infrastructure, regulatory framework, and patient care practices are assessed to understand their impact on blood management solutions. This geographical analysis helps identify market growth areas and potential challenges specific to different parts of the world.
Global Patient Blood Management Segment Analysis
In this report, the global patient blood management market has been segmented by Product, Component, End User, and geography.
Global Patient Blood Management Market, By Product
The Global Patient Blood Management Market has been segmented by Product into Instruments, Accessories, Reagents And Kits and Software.
The field of blood processing and related instruments encompasses a diverse array of devices essential to healthcare systems worldwide. Blood processing devices such as centrifuges and blood cell processors play a critical role in separating blood components efficiently, facilitating various medical procedures including transfusions and research applications. Apheresis machines, plasma separators, and cell salvage systems are integral to blood transfusion devices, enabling the separation and collection of specific blood components for therapeutic purposes. Automated blood culture systems and supporting laboratory equipment are pivotal in detecting and diagnosing infections through efficient screening processes, ensuring timely and accurate treatment decisions. Additionally, diagnostic instruments such as PCR machines, hematology analyzers, NGS platforms, and blood grouping analyzers are indispensable tools in clinical laboratories, enabling precise analysis of blood samples for diagnostics and research.
Complementing these instruments are blood storage devices like medical refrigerators and freezers, which maintain the integrity and viability of blood components and products. Syringes, needles, vials, tubes, blood bags, and other ancillary items form the infrastructure necessary for safe handling, storage, and administration of blood and its derivatives across medical settings. Reagents and kits, including culture media, diagnostic reagents, and assay kits, support the operational needs of these instruments by providing essential chemicals and materials for conducting various tests and procedures. Software solutions streamline workflow management, data analysis, and regulatory compliance in blood processing laboratories, ensuring operational efficiency and adherence to quality standards. Together, these components constitute a comprehensive ecosystem essential for the safe, efficient, and effective management of blood products in healthcare settings globally.
Global Patient Blood Management Market, By Component
The Global Patient Blood Management Market has been segmented by Component into Whole Blood and Plasma.
Patient Blood Management aims to improve patient safety and clinical outcomes through the effective management of blood resources across the healthcare continuum. Whole Blood and Plasma represent critical components in this framework, each playing distinct roles in therapeutic and medical settings. Whole Blood is integral for transfusions in cases of acute blood loss or severe anemia, providing a comprehensive mix of red blood cells, plasma, and platelets. Its use is crucial in emergency situations and surgeries where rapid restoration of blood volume and oxygen-carrying capacity is essential.
Plasma, comprising proteins, electrolytes, and hormones, is vital for conditions requiring clotting factor replacement, such as in hemophilia or other coagulation disorders. The segmentation of the Patient Blood Management market into Whole Blood and Plasma underscores the tailored approaches to managing blood products, aiming to minimize transfusion risks, reduce healthcare costs, and improve patient outcomes through targeted therapeutic interventions. As advancements in medical technology and understanding of blood physiology continue, the segmentation provides healthcare providers with versatile strategies to meet diverse patient needs effectively.
Global Patient Blood Management Market, By End User
The Global Patient Blood Management Market has been segmented by End User into Blood Banks, Hospitals, Diagnostic Clinics, and Pathology Labs.
Blood Banks are a significant end-user segment, where pathology lab equipment plays a crucial role in blood screening, testing, and storage. Accurate testing and analysis are vital for ensuring the safety of blood supplies and meeting regulatory standards, making advanced equipment essential for maintaining high-quality operations.
Hospitals form another major segment, using pathology lab equipment for a wide range of diagnostic procedures that aid in patient treatment plans. From routine blood tests to more complex tissue analysis, hospitals rely on these tools to provide accurate diagnoses that guide medical decisions. The integration of modern laboratory equipment enhances the hospital's ability to deliver timely and effective patient care.
Diagnostic Clinics are specialized centers that focus on providing medical testing services to patients. These clinics use pathology lab equipment to conduct a variety of diagnostic tests, from basic blood work to more detailed investigations such as cytology and histology. The demand for efficient and accurate diagnostic tools helps clinics deliver high-quality service and contribute to patient health management.
Pathology Labs are dedicated facilities that conduct in-depth studies and analyses of biological samples to diagnose diseases and support research. These labs rely heavily on pathology lab equipment for detailed sample processing, staining, and microscopic examination. The advanced capabilities of these tools enhance the lab's ability to perform high-precision diagnostics and contribute to groundbreaking medical research and discoveries.
Global Patient Blood Management Market, By Geography
In this report, the Global Patient Blood Management Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Patient Blood Management Market Share (%), by Geographical Region, 2024
North America, comprising the United States and Canada, leads in advanced healthcare infrastructure and stringent regulatory frameworks, fostering significant adoption of patient blood management strategies. Europe follows closely, with countries like Germany and the UK emphasizing cost-effective healthcare delivery and patient safety, driving the implementation of blood conservation techniques and transfusion alternatives. The Asia Pacific region, encompassing rapidly developing economies such as China, India, and Japan, is witnessing robust growth due to rising healthcare expenditure, increasing awareness about blood transfusion risks, and efforts to enhance healthcare quality.
The Middle East and Africa region faces unique challenges, including varying healthcare access and infrastructure across countries. Nevertheless, initiatives to improve blood transfusion practices and manage blood supplies are gaining traction in countries like Saudi Arabia and South Africa. Latin America, characterized by a mix of public and private healthcare systems, is also seeing strides in patient blood management, driven by initiatives to reduce healthcare costs and enhance patient outcomes. These regional dynamics underscore the global evolution towards comprehensive patient blood management strategies aimed at improving clinical outcomes, ensuring patient safety, and optimizing healthcare resource utilization across diverse healthcare landscapes.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Patient Blood Management Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Development of targeted therapies reducing transfusions
- Integration of PBM into clinical guidelines
- Technological innovations in blood diagnostics
-
Adoption of electronic health records - The adoption of Electronic Health Records (EHRs) has revolutionized healthcare by digitizing patient information, enhancing accessibility, and improving overall care coordination. EHR systems allow healthcare providers to securely store and retrieve patient data, facilitating comprehensive and real-time access to medical histories, test results, and treatment plans. This integration supports clinical decision-making processes, reduces medical errors, and enhances patient safety by ensuring healthcare providers have accurate and up-to-date information at the point of care.
EHR adoption promotes efficiency in healthcare delivery, streamlining administrative tasks such as billing and scheduling, which ultimately reduces costs and enhances the overall patient experience. Challenges such as initial implementation costs, data privacy concerns, and interoperability issues between different EHR systems remain significant barriers that healthcare organizations need to address to maximize the benefits of digital health records fully.
Restraints
- Integration challenges in healthcare workflows
- Variability in patient response to PBM
-
Concerns over efficacy of blood conservation devices - There are increasing concerns regarding the efficacy and outcomes associated with blood conservation devices used in healthcare settings. These devices are designed to minimize the need for blood transfusions by collecting, filtering, and reinfusing a patient's own blood during surgical procedures or in cases of blood loss. While blood conservation devices aim to reduce the risks associated with allogeneic blood transfusions, such as infection and immune reactions, their effectiveness in different clinical scenarios and patient populations is a subject of ongoing debate.
Issues such as device variability, appropriate patient selection, and the need for comprehensive training in device use among healthcare providers are critical factors influencing their adoption and impact on patient outcomes. Healthcare organizations must navigate regulatory requirements and evidence-based guidelines to ensure safe and effective use of these devices, balancing clinical benefits with potential risks and costs associated with their implementation.
Opportunities
- Improvement in blood conservation device safety
- Expansion of blood banks and donation networks
- Integration of genetic testing in PBM
-
Enhanced interoperability of PBM software - PBM software integrates various clinical data points, including laboratory results, patient demographics, and procedural information, to support evidence-based decision-making in blood management strategies. By enabling seamless communication and data exchange between different healthcare IT systems and departments, interoperable PBM software enhances care coordination, reduces redundant testing, and supports personalized treatment plans tailored to individual patient needs.
Interoperability facilitates real-time monitoring of blood product inventory, enhances compliance with transfusion guidelines, and promotes transparency in clinical decision-making processes. As healthcare systems continue to prioritize value-based care and patient safety, the interoperability of PBM software is crucial for achieving efficient resource utilization, reducing healthcare costs, and improving overall quality of care for patients undergoing surgical procedures or managing chronic conditions requiring blood products.
Competitive Landscape Analysis
Key players in Global Patient Blood Management Market include
- Biomrieux SA
- Bio-Rad Laboratories, Inc.
- Fresenius Se & Co. KGaA
- Danaher Corporation
- Hitachi, Ltd.
- Abbott Laboratories
- F. Hoffmann-La Roche LTD
- Terumo Corporation
- Stafa Cellular Therapy
- B. Braun Melsungen AG
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Component
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Patient Blood Management Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Development of targeted therapies reducing transfusions
- Integration of PBM into clinical guidelines
- Technological innovations in blood diagnostics
- Adoption of electronic health records
- Restraints
- Integration challenges in healthcare workflows
- Variability in patient response to PBM
- Concerns over efficacy of blood conservation devices
- Opportunities
- Improvement in blood conservation device safety
- Expansion of blood banks and donation networks
- Integration of genetic testing in PBM
- Enhanced interoperability of PBM software
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Patient Blood Management Market, By Product, 2021 - 2031 (USD Million)
- Instruments
- Blood Processing Devices
- Centrifuges
- Blood Cell Processors
- Blood Transfusion Devices
- Apheresis Machines
- Plasma & Plasma Component Separators
- Cell Salvage Systems
- Others
- Blood Culture Screening Devices
- Automated Blood Culture Systems
- Supporting Laboratory Equipment
- Diagnostic & Testing Instruments
- PCR Instruments
- Hematology Analyzers
- NGS Platforms
- Blood Grouping Analyzers
- Blood Storage Devices
- Medical Refrigerators
- Medical Freezers
- Syringes & Needles
- Vials & Tubes
- Blood Bags
- Others
- Blood Processing Devices
- Reagents & Kits
- Culture Media
- Reagents
- Kits
- Others
- Software
- Instruments
- Global Patient Blood Management Market, By Component, 2021 - 2031 (USD Million)
- Whole Blood
- Plasma
- Global Patient Blood Management Market, By End User, 2021 - 2031 (USD Million)
- Blood Banks
- Hospitals
- Diagnostic Clinics
- Pathology Labs
- Global Patient Blood Management Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Patient Blood Management Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape Analysis
- Company Profiles
- Biomrieux SA
- Bio-Rad Laboratories, Inc.
- Fresenius Se & Co. KGaA
- Danaher Corporation
- Hitachi, Ltd.
- Abbott Laboratories
- F. Hoffmann-La Roche LTD
- Terumo Corporation
- Stafa Cellular Therapy
- B. Braun Melsungen AG
- Company Profiles
- Analyst Views
- Future Outlook of the Market